The findings indicated that the signaling pathways closely associated with these central objectives encompass colorectal cancer, prostate cancer, chemical carcinogenesis through receptor activation, microRNAs in cancer, the PI3K-Akt signaling pathway, resistance to endocrine therapy, apoptosis, and the estrogen pathway. This evidence concerns the gene AKT1 and prostate carcinoma.